A passionate health policy and government affairs professional committed to maximizing access to medicines for patients in need around the world; to informing public policy makers about the innovative value of our medicines and translating policy insights into commercial vision and execution. Global senior-level health economic and policy professional with a distinguished record of providing business and policy expertise and enhancements to shareholder value.Highly respected by senior management as a creative, strategic thinker and problem solver armed with a keen understanding of the intersections of policy and business issues. Adept at identifying new and emerging policy, economic and commercial issues, trends and opportunities and advancing them into concrete value propositions. Experienced collaborating across large-matrix organizations with diverse audiences. An excellent and persuasive communicator with the unique ability to convey complex messages to a wide variety of stakeholders such as senior corporate leadership, government officials, academia, and key opinion and thought leaders.Major issues management responsibility areas include: pricing and access; intellectual property; health technology assessments; biosimilars; international trade and Developing World health issues. Current regional focus is primarily all geographies outside of the United States. In past positions, focus was on U.S. health policy issues. Specialties: Health and Macroeconomics, Pricing and Market Access, Public Policy, Public Affairs, Communications and Issues Management, Strategic Planning, Competitive Intelligence, Immuno-Oncology, Published peer reviewed research in both policy and medical journals.
Listed skills include Market Access, Pharmaceutical Industry, Oncology, Strategic Planning, and 20 others.